Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hilgeroth

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Archiv Der Pharmazie|October 19, 2006
P-glycoprotein effects of cyclic urea HIV protease inhibitor DMP 323 in competitional absorption studiesMartin Richter, Nóra Gyémánt, Joséf Molnár, et al.
European Journal of Medicinal Chemistry|August 30, 2008
Evaluation of substrate and inhibitor properties of a novel MDR modulator H17 towards transmembrane efflux pumpsMartin Richter, Alexandra Richter, Andreas Langner, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 6, 2024
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer CellsPeter Werner, Nikolétta Szemerédi, Gabriella Spengler, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 13, 2013
Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3βAndreas Hilgeroth, Volkmar Tell, Steffi Kramer, et al.
Molecules (Basel, Switzerland)|April 5, 2018
Discovery of Novel Enhancers of Isoniazid Toxicity in <i>Mycobacterium tuberculosis</i>Fabian Lentz, Norbert Reiling, Ana Martins, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 14, 2014
Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 InhibitorsAndreas Hilgeroth, Marc Hemmer, Sebastian Neuber, et al.
Bioorganic & Medicinal Chemistry|June 11, 2015
Discovery of substituted 1,4-dihydroquinolines as novel class of ABCB1 modulatorsMarc Hemmer, Sören Krawczyk, Ina Simon, et al.
Chemmedchem|November 15, 2007
Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitorsBurkhardt Voigt, Martin Krug, Christoph Schächtele, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2008
Novel insight into inhibitor binding of highly symmetric HIV-1 proteaseJörg Wollmann, Christiane Baumert, German Erlenkamp, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 10, 2024
Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in <i>S. aureus</i> Strains Including MRSAPeter Werner, David Kreutzer, Nikoletta Szemeredi, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Archiv Der Pharmazie|October 19, 2006
P-glycoprotein effects of cyclic urea HIV protease inhibitor DMP 323 in competitional absorption studiesMartin Richter, Nóra Gyémánt, Joséf Molnár, et al.
European Journal of Medicinal Chemistry|August 30, 2008
Evaluation of substrate and inhibitor properties of a novel MDR modulator H17 towards transmembrane efflux pumpsMartin Richter, Alexandra Richter, Andreas Langner, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 6, 2024
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer CellsPeter Werner, Nikolétta Szemerédi, Gabriella Spengler, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 13, 2013
Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3βAndreas Hilgeroth, Volkmar Tell, Steffi Kramer, et al.
Molecules (Basel, Switzerland)|April 5, 2018
Discovery of Novel Enhancers of Isoniazid Toxicity in <i>Mycobacterium tuberculosis</i>Fabian Lentz, Norbert Reiling, Ana Martins, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 14, 2014
Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 InhibitorsAndreas Hilgeroth, Marc Hemmer, Sebastian Neuber, et al.
Bioorganic & Medicinal Chemistry|June 11, 2015
Discovery of substituted 1,4-dihydroquinolines as novel class of ABCB1 modulatorsMarc Hemmer, Sören Krawczyk, Ina Simon, et al.
Chemmedchem|November 15, 2007
Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitorsBurkhardt Voigt, Martin Krug, Christoph Schächtele, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2008
Novel insight into inhibitor binding of highly symmetric HIV-1 proteaseJörg Wollmann, Christiane Baumert, German Erlenkamp, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 10, 2024
Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in <i>S. aureus</i> Strains Including MRSAPeter Werner, David Kreutzer, Nikoletta Szemeredi, et al.
Pageof 7